ArticleJournal of epidemiology and global health2025
Preliminary Genetic Characterization of Enteroviruses in Pediatric HFMD Cases: First Data from Jeddah, Saudi Arabia.
Article in Journal of epidemiology and global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identification of key amino acids defining conformational neutralizing epitopes of coxsackievirus A5 using monoclonal antibody escape mutants.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundHand, foot, and mouth disease (HFMD) is a prevalent contagious viral illness primarily affecting children under five years old globally, with potential for severe complications. It a common pediatric illness primarily caused by enteroviruses (EV), yet data on its epidemiology and viral diversity in Saudi Arabia remain scarce. This study addresses this knowledge gap by providing the first molecular prevalence data for HFMD in Saudi Arabia, aiming to determine the genomic serotypes of enterovirus (EV) infections in pediatric HFMD cases and investigate their association with disease outcome.
methodsThirty-four pediatric patients clinically diagnosed with HFMD in Jeddah between November 2023 and June 2024 were enrolled. Oral and throat swabs were analyzed using real-time RT-PCR using broad-spectrum EV detection and conventional RT-PCR targeting the 5'-noncoding regions, followed by Sanger sequencing and phylogenetic analysis for comprehensive serotype identification.
resultsOf the 34 cases, enteroviruses were detected in 82.35% (28/34) of cases. The majority of cases were male (64.7%) and under six years old (61.67%), with a median age of 4.88 ± 3.19 years. Clinical symptoms predominantly included typical rashes on the head, face, and limbs (96.67%), fever (73.53%), and skin itchiness (58.82%). Sequence analysis based on 5'-NCR identified five EV serotypes: CV-A6 (50%), CV-A16 (35.7%), CV-A10 (7.1%), EV-A71 (3.6%), and CV-A5 (3.6%). CV-A6 was the predominant serotype and detected across all age groups, with the highest subtype diversity in children ≤ 3 years. Phylogenetic analysis revealed that Saudi strains were closely related to global isolates, especially from Asia and Europe, suggesting multiple introductions and localized transmission.
conclusionThis pilot study reveals substantial genetic diversity and co-circulation of multiple EV serotypes among HFMD cases in Jeddah. The predominance of CV-A6 aligns with recent global trends, underscoring the need for ongoing molecular surveillance and public health preparedness, including vaccine strategy development targeting emerging serotypes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.